GILD Snapshot
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Market Capitalization$85,059,510,000
Price to Sales3.10
Earnings per Share$5.8400
PE Ratio11.6
Most Recent Close$67.8100
52 Week High$74.12
52 Week Low$58.88
50-Day Moving Average$70.43
200-Day Moving Average$68.86
All data are from Alpha Vantage as of today. For more infomation on GILD see Stock Dividend, Valuation, Price and Financial Data for Investors